EYEG

EyeGate Pharmaceuticals Inc.

Price

$35.59

return (12m)

p/e

-23.68

p/bv

14.24

DIVIDEND YIELD

5.00%

EYEG price

EyeGate Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment EYEG

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals EYEG

Valuation

P/E

-23.68

Sector -2.34

Industry 11.10

P/BV

14.24

Sector 2.17

Industry 3.33

P/Revenue (PSR)

Sector 2.00

Industry 1.71

EV/EBITDA

Sector -23.69

Industry -398.52

EV/EBIT

Sector -36.60

Industry -80.73

P/EBITDA

-23.08

Sector -0.10

Industry 8.30

P/EBIT

-22.99

Sector -2.08

Industry 5.69

P/Total Assets

9.69

Sector 1.18

Industry 1.57

P/Net Current Assets

Sector -10.91

Industry -3.38

P/Working Capital

Sector 0.09

Industry 10.51

EPS

-1.48

Sector -0.93

Industry 1.10

BVPS

2.46

Sector 3.87

Industry 14.82

Efficiency

Gross Margin

100.00%

Sector 44.28%

Industry 29.23%

EBITDA Margin

Sector -291.45%

Industry 4.29%

EBIT Margin

Sector -195.44%

Industry 1.44%

Operating Margin

-100.00%

Sector -25.72%

Industry 2.16%

Net Profit Margins

-100.00%

Sector -30.19%

Industry 2.77%

Asset Turnover

0.00

Sector 0.12

Industry 0.27

Profitability

ROE

-60.14%

Sector -34.71%

Industry 6.97%

ROA

-40.92%

Sector -28.76%

Industry 2.97%

ROIC

Sector -441.27%

Industry -5.31%

Dividends

Dividend yield

5.00%

Sector -

Industry 0.01%

Payout

Sector -

Industry 0.54%

Debt

Current Ratio

Sector 1.87

Industry 1.51

Net Debt / EBITDA

Sector -2.18

Industry -1.68

Net Debt / EBIT

Sector -0.74

Industry -7.00

Net Debt / Equity

Sector -0.34

Industry 0.05

Gross Debt / Equity

Sector -0.64

Industry 0.35

Equity/Assets

0.68

Sector 0.43

Industry 0.46

Liabilities/Assets

0.32

Sector 0.46

Industry 0.52

Growth

5Y Revenue CAGR

14.87%

Sector -

Industry -

5Y Earnings CAGR

5.41%

Sector -

Industry -

Fundamentals EYEG

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
EYEG EyeGate Pharmaceuticals Inc.	$35.59	8.79%	5.00%	-23.68	14.24	-60.14%	-100.00%
EW Edwards Lifesciences Corp.	$78.21	12.69%	0.00%	45.55	4.82	10.58%	17.34%
BSX Boston Scientific Corp.	$63.80	-31.89%	0.00%	18.45	2.54	13.78%	17.29%
ABT Abbott Laboratories	$101.06	-18.35%	0.00%	25.64	3.09	12.06%	13.91%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
ALGN Align Technology Inc.	$184.69	12.52%	0.00%	27.86	2.89	10.36%	10.50%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

EYEG Historical Dividends

current DY: 5.00%

5-year average DY: 5.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	03/02/2026	03/05/2026	0.13930000
Dividends	02/02/2026	02/05/2026	0.14110000
Dividends	12/31/2025	01/05/2026	0.18530000
Dividends	12/01/2025	12/04/2025	0.13910000
Dividends	11/03/2025	11/06/2025	0.13860000
Dividends	10/01/2025	10/06/2025	0.13610000
Dividends	09/02/2025	09/05/2025	0.14170000
Dividends	08/01/2025	08/06/2025	0.14980000
Dividends	07/01/2025	07/07/2025	0.14200000
Dividends	06/02/2025	06/05/2025	0.15100000
Dividends	05/01/2025	05/06/2025	0.15010000
Dividends	04/01/2025	04/04/2025	0.15300000
Dividends	03/03/2025	03/06/2025	0.13900000
Dividends	02/03/2025	02/06/2025	0.14100000
Dividends	12/30/2024	01/02/2025	0.47100000
Dividends	12/02/2024	12/05/2024	0.14600000
Dividends	11/01/2024	11/06/2024	0.15150000
Dividends	10/01/2024	10/04/2024	0.14750000
Dividends	09/03/2024	09/06/2024	0.14920000
Dividends	08/01/2024	08/06/2024	0.15460000
Dividends	07/01/2024	07/05/2024	0.14990000
Dividends	06/03/2024	06/06/2024	0.15390000
Dividends	05/02/2024	05/07/2024	0.14840000
Dividends	04/02/2024	04/05/2024	0.15720000
Dividends	03/04/2024	03/07/2024	0.14860000
Dividends	02/02/2024	02/07/2024	0.14760000
Dividends	12/29/2023	01/04/2024	0.09130000

ABOUT EyeGate Pharmaceuticals

EyeGate Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

States of America

28 years

Founded: 1998

2015

Time since IPO - 11 years

14

Employees

EyeGate Pharmaceuticals Inc. (States of America) is listed on the Nasdaq and has a market capitalization of $247.03 million, with shareholders equity totaling $17.35 million.

The company employs approximately 14 people and operates in the Saúde sector, within the Produtos Farmacêuticos industry.

Over the past 12 months, EyeGate Pharmaceuticals Inc. reported $24.12 Thousand in revenue, generating net income of $-10.43 million.

Key financial metrics include a P/E ratio of -23.68, a price-to-book (P/B) ratio of 14.24, and a trailing twelve-month dividend yield of 5.00%.

The company trades under the ticker EYEG.

Market cap

$247.03 million

Net worth

$17.35 million

$17,348,046.00

Assets

$25.49 million

$25,493,339.00

Total Shares Outstanding

7.06 million

7,062,000

Average Daily Trading Volume

$101.74

Sector

Saúde

Industry

Produtos Farmacêuticos

EYEG

EYEG revenue and profits

Financial Results EYEG

DRAG THE FRAME TO SEE MORE DATA

EYEG cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$77.63 34,88% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$272.65 --5,23% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$37.26 38,72% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$196.30 --14,19% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$47.64 --3,72% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$923.03 21,62% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$498.78 47,18% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$153.41 34,63% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56